Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy

CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children

NCT07023744 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Cannabidiol in Children With Refractory Epileptic Encephalopathy

NCT03024827 ·Status: UNKNOWN ·Phase: PHASE1

A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy

NCT02783092 ·Status: UNKNOWN ·Phase: PHASE3

Epidiolex in Typical Absence Seizures

NCT04899050 ·Status: COMPLETED ·Phase: PHASE4

Expanded Use of Cannabidiol Oral Solution

NCT03196934 ·Status: NO_LONGER_AVAILABLE

The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy

NCT02523183 ·Status: UNKNOWN

An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes

NCT02224573 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy

NCT05678881 ·Status: TERMINATED ·Phase: PHASE1

Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

NCT03336242 ·Status: TERMINATED ·Phase: PHASE2

Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder

NCT02318602 ·Status: COMPLETED ·Phase: PHASE3

Epidiolex and Drug Resistant Epilepsy in Children

NCT02397863 ·Status: AVAILABLE

An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

NCT02607904 ·Status: COMPLETED ·Phase: PHASE2

Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy

NCT05803434 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

NCT02224560 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

NCT07233239 ·Status: RECRUITING ·Phase: PHASE1

A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

NCT02607891 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy

NCT02987114 ·Status: COMPLETED ·Phase: PHASE2

Medication Adherence in Individuals With Epilepsy

NCT01566500 ·Status: COMPLETED

Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

NCT03355300 ·Status: TERMINATED ·Phase: PHASE2

Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy

NCT05512130 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

NCT02091375 ·Status: COMPLETED ·Phase: PHASE3

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

NCT02544750 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy

NCT01906398 ·Status: UNKNOWN ·Phase: PHASE2

A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

NCT02565108 ·Status: COMPLETED ·Phase: PHASE2

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

NCT00210652 ·Status: COMPLETED ·Phase: PHASE2